FDA Drug Application (202161) for DESONIDE by TARO

Back to FDA Applications sponsored by TARO

Application Number202161
Product Number001
FormLOTION;TOPICAL
Dosage0.05%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDESONIDE
Active IngredientDESONIDE

Active IngredientCount
List of drugs with Active Ingredient DESONIDE5


Back to FDA Applications sponsored by TARO